These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10683544)

  • 41. [Hepatitis B in Poland in 2003].
    Kuszewski K
    Przegl Epidemiol; 2005; 59(2):297-301. PubMed ID: 16190533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
    Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
    Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infection.
    Holliday SM; Faulds D
    Pharmacoeconomics; 1994 Feb; 5(2):141-71. PubMed ID: 10146907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Are teenagers immunized in infancy still protected against hepatitis B?].
    Pokorska-Lis M; Marczyńska M
    Przegl Lek; 2010; 67(1):13-7. PubMed ID: 20509565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
    Bar-On ES; Goldberg E; Fraser A; Vidal L; Hellmann S; Leibovici L
    Cochrane Database Syst Rev; 2009 Jul; (3):CD005530. PubMed ID: 19588375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B and C virus infection in Polish children with malignancies.
    Januszkiewicz D; Wysocki J; Nowak J
    Eur J Pediatr; 1997 Jun; 156(6):454-6. PubMed ID: 9208241
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. WHO strategy for the global elimination of new cases of hepatitis B.
    Ghendon Y
    Vaccine; 1990 Mar; 8 Suppl():S129-33; discussion S134-8. PubMed ID: 2139280
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strategy vaccination against Hepatitis B in China.
    Liao X; Liang Z
    Hum Vaccin Immunother; 2015; 11(6):1534-9. PubMed ID: 25881006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
    Dhillon S
    BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Global progress toward universal childhood hepatitis B vaccination, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Changes in the epidemiological situation of hepatitis B in Kielce region, after introduction of vaccination of infants against hepatitis B].
    Patrzałek M; Tarnowska H
    Przegl Epidemiol; 1999; 53(1-2):181-5. PubMed ID: 10402866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
    Zhao S; Xu Z; Lu Y
    Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update on hepatitis B vaccination in Italy 10 years after its implementation.
    Zanetti AR
    Vaccine; 2001 Mar; 19(17-19):2380-3. PubMed ID: 11257364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Public health impact of Infanrix hexa (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 1: Evolution of hepatitis B vaccine coverage rates in infants aged less than 27 months, in the general population - the PopCorn study.
    Gaudelus J; Vié le Sage F; Dufour V; Lert F; Texier N; Pouriel M; Tehard B; Bréart G
    Rev Epidemiol Sante Publique; 2016 Feb; 64(1):23-32. PubMed ID: 26748972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age.
    Viviani S; Jack A; Hall AJ; Maine N; Mendy M; Montesano R; Whittle HC
    Vaccine; 1999 Aug; 17(23-24):2946-50. PubMed ID: 10462228
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
    Halota W; Muszyńska M; Pawłowska M
    Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
    Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
    JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Seroepidemiological study and program of vaccination against hepatitis B in school children in Extremadura].
    Gimeno Ortiz A; Jiménez Romano R; Zarallo Barbosa T
    Rev Sanid Hig Publica (Madr); 1993; 67(5):369-76. PubMed ID: 7732304
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hepatitis B in Poland in 2010].
    Stepień M; Czarkowski MP
    Przegl Epidemiol; 2012; 66(2):277-85. PubMed ID: 23101217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.